Allos S.A. (BVMF:ALOS3)

Market Cap	10.99B
Revenue (ttm)	2.82B
Net Income (ttm)	862.12M
Shares Out	500.76M
EPS (ttm)	1.61
PE Ratio	13.61
Forward PE	15.98
Dividend	0.60 (2.78%)
Ex-Dividend Date	Aug 22, 2025

Volume	3,112,000
Average Volume	4,299,428
Open	21.70
Previous Close	21.59
Day's Range	21.54 - 21.90
52-Week Range	17.16 - 24.04
Beta	0.17
RSI	49.63
Earnings Date	Aug 12, 2025

About Ligand Pharmaceuticals

Allos S.A. provides planning, development, administration, and sales services to third-party shopping centers in Brazil. It provides administration services, including financial, legal, commercial, and operational management; brokerage and advisory services; and operation of parking lots in shopping centers; as well as engages in management of shopping malls and condominiums. The company was formerly known as Aliansce Shopping Centers S.A. and changed its name to Allos S.A. in October 2023. Allos S.A. is headquartered in Rio De Janeiro, Brazil.

• Industry: Real Estate Services
• Sector: Real Estate
• CEO: Rafael Guimarães
• Employees: 1,062
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: ALOS3

Financial Performance

In 2024, Allos's revenue was 2.82 billion, an increase of 0.51% compared to the previous year's 2.80 billion. Earnings were 698.51 million, a decrease of -79.38%.